Patent ID: 6977251

Claim:
A composition of matter comprising a carrier and a tumor inhibiting effective amount of a compound selected from the group consisting of 5-androstene-3β,17α-diol and an ester or ether thereof of the formula: wherein, R independently are H, alkenyl of 2-8 carbons, alkyl of 1-8 carbons, phenylalkyl of 1-4 carbons, phenyl or COR 2 , R 2 independently are H, alkyl of 1-8 carbons, alkenyl of 2-8 carbons, phenylalkyl wherein the alkyl has 1-4 carbons or phenyl, wherein any phenyl moiety optionally has up to three substituents chosen from among hydroxy, carboxy of 1-4 carbons, halo, alkoxy of 1-4 carbons, alkyl of 1-4 carbons, or alkenyl of 2-4 carbons and wherein any alkyl optionally is a straight chain, branched chain, or the alkyl optionally is wholly or partially cyclized, wherein the composition is a formulation for oral, parenteral, buccal, sublingual, endotracheal or aerosol administration.